Gastrin-releasing Peptide Receptor Antagonist Effects on an Animal Model of Sepsis-Reference-Cited by-同舟云学术

Gastrin-releasing Peptide Receptor Antagonist Effects on an Animal Model of Sepsis

Published:2006-01 Issue:1 Volume:173 Page:84-90
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Dal-Pizzol Felipe,Di Leone Luciane Pons,Ritter Cristiane,Martins Márcio Rodrigo,Reinke Adalisa,Pens Gelain Daniel,Zanotto-Filho Alfeu,de Souza Luiz Fernando,Andrades Michael,Barbeiro Denise Frediani,Bernard Elena Aida,Cammarota Martin,Bevilaqua Lia R. M.,Soriano Francisco Garcia,Cláudio José,Moreira Fonseca,Roesler Rafael,Schwartsmann Gilberto

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference30 articles.

1. Epidemiology of Sepsis Syndrome in 8 Academic Medical Centers

2. The Pathophysiology and Treatment of Sepsis

3. Risk and the Efficacy of Antiinflammatory Agents

4. Cathelicidin Peptide Sheep Myeloid Antimicrobial Peptide-29 Prevents Endotoxin-induced Mortality in Rat Models of Septic Shock

5. Treatment with N-acetylcysteine plus deferoxamine protects rats against oxidative stress and improves survival in sepsis*

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gastrin-releasing peptide receptor antagonist RC-3095 inhibits Porphyromonas gingivalis lipopolysaccharide-accelerated atherosclerosis by suppressing inflammatory responses in endothelial cells and macrophages;Inflammation Research;2024-08-20

2. Bombesins: A New Frontier in Hybrid Compound Development;Pharmaceutics;2023-11-07

3. Genetic and pharmacological inhibition of GRPR protects against acute kidney injury via attenuating renal inflammation and necroptosis;Molecular Therapy;2023-09

4. GRP/GRPR enhances alcohol-associated liver injury through the IRF1-mediated Caspase-1 inflammasome and NOX2-dependent ROS pathway;Hepatology;2023-07-05

5. Novel insight on GRP/GRPR axis in diseases;Biomedicine & Pharmacotherapy;2023-05